Resumo
Definição
História e exame físico
Fatores de risco
- genética
- infecção
- trauma local
- medicações
- estresse
- tabagismo
- etnia
- bebidas alcoólicas
- índice de massa corporal (IMC) mais elevado
Investigações diagnósticas
Algoritmo de tratamento
Colaboradores
Autores
Andrea Chiricozzi, MD
Assistant Professor
University of Pisa
Consultant Dermatologist
University Hospital of Pisa
Pisa
Italy
Declarações
AC has served as an advisory board member and consultant and has received fees and speaker's honoraria or has participated in clinical trials for AbbVie, Almirall, Biogen, Fresenius Kabi, Leo Pharma, Lilly, Janssen, Novartis, Sanofi Genzyme, and UCB Pharma; AC is also an author of a reference cited in this topic.
Agradecimentos
Dr Andrea Chiricozzi would like to gratefully acknowledge Dr April W. Armstrong and Dr Tsu-Yi Chuang, previous contributors to this topic.
Declarações
TC declares that he has no competing interests. AWA is an investigator and consultant for Abbott, Amgen, and Janssen; AWA is also an author of references cited in this topic.
Revisores
David Burden, MD, FRCP
Western Infirmary, Glasgow
Consultant Dermatologist Dermatology
Glasgow
UK
Declarações
DB has been reimbursed as a consultant, researcher, and lecturer for Abbott, Leo, Pfizer, Merck, Janssen-Cilag, and Novartis.
Paradi Mirmirani, MD
Physician
Department of Dermatology
Kaiser Permanente Vallejo Medical Center
Vallejo
CA
Declarações
PM declares that she has no competing interests.
Diretrizes
- EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris – part 2: specific clinical and comorbid situations
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures
Calculadoras
Mais Calculadoras
O uso deste conteúdo está sujeito ao nosso aviso legal